Hepion Pharmaceuticals, Inc. (HEPA) has a consensus analyst rating of Hold, based on 3 analysts covering the stock. Of those, 1 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for HEPA is $70.00, representing a +145,733.3% upside from the current price of $0.048. Price targets range from a low of $70.00 to a high of $70.00.
